| Zofenopril |
20030714 |
ZOFEN, Film coated tablet, 7.5, mg, Pack: 28 |
Berlin - Chemie AG, Германия |
A.Menarini Manufacturing Logistics and Services S.r.L., Italy; Menarini - Von Heiden GmbH - Germany |
5.87 |
1.17 |
7.04 |
7% |
0.41 |
6.28 |
1.26 |
7.54 |
20% |
1.17 |
7.45 |
1.49 |
8.94 |
промяна на обстоятелства решение КЦPP-326/16.03.2012; корекционно решение НСР-9132/27.04.2016.; Цената е прехвърлена в регистъра на пределните цени с решение НСР-9515/09.06.2016 (в сила от 02.07.2016) |
КЦ-48/21.04.2008 |
02.07.2016 |
02.07.2016 |
Заличен |
33 |
| Zofenopril |
13383/14.06.2006 |
ZOFEN, Film coated tablet, 7.5, mg, Pack: 28 |
Berlin - Chemie AG, Германия |
A.Menarini Manufacturing Logistics and Services S.r.L., Italy; Menarini - Von Heiden GmbH - Germany |
5.87 |
1.17 |
7.04 |
7% |
0.41 |
6.28 |
1.26 |
7.54 |
20% |
1.17 |
7.45 |
1.49 |
8.94 |
промяна на обстоятелства решение КЦPP-326/16.03.2012; корекционно решение НСР-9132/27.04.2016. |
КЦ-48/21.04.2008 |
23.05.2008 |
23.05.2008 |
Неактивен |
33 |
| Zofenopril |
13383/14.06.2006 |
ZOFEN, Film coated tablet, 7.5, mg, Pack: 28 |
Berlin - Chemie AG, Германия |
A.Menarini Manufacturing Logistics and Services S.r.L., Italy; Menarini - Von Heiden GmbH - Germany |
5.87 |
1.17 |
7.04 |
7% |
0.41 |
6.28 |
1.26 |
7.54 |
20% |
1.17 |
7.45 |
1.49 |
8.94 |
промяна на обстоятелства решение КЦPP-326/16.03.2012 |
КЦ-48/21.04.2008 |
23.05.2008 |
23.05.2008 |
Неактивен |
33 |
| Zofenopril |
13384/14.06.2006 |
ZOFEN, Film coated tablet, 30, mg, Pack: 28 |
Berlin - Chemie AG, Германия |
A.Menarini Manufacturing Logistics and Services S.r.L., Italy; Menarini - Von Heiden GmbH - Germany |
13.69 |
2.74 |
16.43 |
6% |
0.82 |
14.51 |
2.9 |
17.41 |
18% |
2.46 |
16.97 |
3.39 |
20.36 |
промяна на обстоятелства решение КЦPP-327/16.03.2012 |
КЦ-48/21.04.2008 |
23.05.2008 |
23.05.2008 |
Неактивен |
1974 |
| Zofenopril, Hydrochlorothiazide |
20130236 |
Zofen plus, Film coated tablet, 30 mg/12.5, mg, Pack: 28 |
Menarini International Operations Luxembourg S.A., Люксембург |
A. MENARINI Manufacturing Logistics and Services Srl, Италия; Menarini –Von Heyden GmbH, Германия |
14.71 |
2.94 |
17.65 |
6% |
0.88 |
15.59 |
3.12 |
18.71 |
18% |
2.65 |
18.24 |
3.65 |
21.89 |
корекционно решение НСР-10561/10.10.2016 |
НСР-5512/29.01.2015; НСР-10452/29.09.2016 |
14.10.2016 |
02.11.2016 |
Активен |
3527 |
| Zofenopril, Hydrochlorothiazide |
20130236 |
Zofen plus, Film coated tablet, 30 mg/12.5 mg, mg, Pack: 28 |
Menarini International Operations Luxembourg S.A., Люксембург |
A. MENARINI Manufacturing Logistics and Services Srl, Италия; Menarini –Von Heyden GmbH, Германия |
15.02 |
3 |
18.02 |
6% |
0.9 |
15.92 |
3.18 |
19.1 |
18% |
2.7 |
18.62 |
3.72 |
22.34 |
|
НСР-5512/29.01.2015 |
12.02.2015 |
12.02.2015 |
Неактивен |
3527 |
| Ondansetron |
20011017 |
Zofran, Film coated tablet, 4, mg, Pack: 10 |
Novartis Pharma GmbH, Германия |
GlaxoSmith Kline Pharmaceuticals S.A. Poland; Novartis Pharma GmbH, Германия |
27.83 |
5.57 |
33.4 |
6% |
1.67 |
29.5 |
5.9 |
35.4 |
18% |
5.01 |
34.51 |
6.9 |
41.41 |
промяна на обстоятелства НСР-9175/27.04.2016; НСР-17807/24.01.2019 |
НСР-2492/24.01.2014; НСР-18319/28.03.2019 |
20.02.2014 |
02.05.2019 |
Заличен |
2488 |
| Ondansetron |
20011017 |
Zofran, Film coated tablet, 4, mg, Pack: 10 |
Novartis Pharma GmbH, Германия |
GlaxoSmith Kline Pharmaceuticals S.A. Poland; Novartis Pharma GmbH, Германия |
27.83 |
5.57 |
33.4 |
6% |
1.67 |
29.5 |
5.9 |
35.4 |
18% |
5.01 |
34.51 |
6.9 |
41.41 |
промяна на обстоятелства НСР-9175/27.04.2016; НСР-17807/24.01.2019 |
НСР-2492/24.01.2014 |
20.02.2014 |
02.03.2019 |
Неактивен |
2488 |
| Ondansetron |
20011017 |
Zofran, Film coated tablet, 4, mg, Pack: 10 |
Novartis Pharma GmbH, Германия |
GlaxoSmith Kline Pharmaceuticals S.A. Poland; Glaxo Wellcome S.A., Spain |
27.83 |
5.57 |
33.4 |
6% |
1.67 |
29.5 |
5.9 |
35.4 |
18% |
5.01 |
34.51 |
6.9 |
41.41 |
промяна на обстоятелства НСР-9175/27.04.2016 |
НСР-2492/24.01.2014 |
20.02.2014 |
20.02.2014 |
Неактивен |
2488 |
| Ondansetron |
20011017 |
Zofran, Film coated tablet, 4, mg, Pack: 10 |
Novartis Pharma GmbH, Германия |
GlaxoSmith Kline Pharmaceuticals S.A. Poland; Glaxo Wellcome S.A., Spain |
27.83 |
5.57 |
33.4 |
6% |
1.67 |
29.5 |
5.9 |
35.4 |
18% |
5.01 |
34.51 |
6.9 |
41.41 |
промяна на обстоятелства НСР-9175/27.04.2016 |
НСР-2492/24.01.2014 |
20.02.2014 |
20.02.2014 |
Неактивен |
2488 |
| Ondansetron |
20011018 |
Zofran, Film coated tablet, 8, mg, Pack: 10 |
Novartis Pharma GmbH, Германия |
GlaxoSmith Kline Pharmaceuticals S.A. Poland; Glaxo Wellcome S.A., Spain |
21.87 |
4.37 |
26.24 |
6% |
1.31 |
23.18 |
4.64 |
27.82 |
18% |
3.94 |
27.12 |
5.42 |
32.54 |
промяна на обстоятелства НСР-9176/27.04.2016 |
КЦРР-2555/14.03.2013 |
29.03.2013 |
29.03.2013 |
Активен |
1729 |
| Ondansetron |
20011018 |
Zofran, Film coated tablet, 8, mg, Pack: 10 |
Novartis Pharma GmbH, Германия |
GlaxoSmith Kline Pharmaceuticals S.A. Poland; Glaxo Wellcome S.A., Spain |
21.87 |
4.37 |
26.24 |
6% |
1.31 |
23.18 |
4.64 |
27.82 |
18% |
3.94 |
27.12 |
5.42 |
32.54 |
промяна на обстоятелства НСР-9176/27.04.2016 |
КЦРР-2555/14.03.2013 |
29.03.2013 |
29.03.2013 |
Неактивен |
1729 |
| Ondansetron |
20011017 |
Zofran, Film coated tablet, 4, mg, Pack: 10 |
ГлаксоСмитКлайн ЕООД, България |
GlaxoSmith Kline Pharmaceuticals S.A. Poland; Glaxo Wellcome S.A., Spain |
27.83 |
5.57 |
33.4 |
6% |
1.67 |
29.5 |
5.9 |
35.4 |
18% |
5.01 |
34.51 |
6.9 |
41.41 |
|
НСР-2492/24.01.2014 |
20.02.2014 |
20.02.2014 |
Неактивен |
2488 |
| Ondansetron |
20011018 |
Zofran, Film coated tablet, 8, mg, Pack: 10 |
ГлаксоСмитКлайн ЕООД, България |
GlaxoSmith Kline Pharmaceuticals S.A. Poland; Glaxo Wellcome S.A., Spain |
21.87 |
4.37 |
26.24 |
6% |
1.31 |
23.18 |
4.64 |
27.82 |
18% |
3.94 |
27.12 |
5.42 |
32.54 |
|
КЦРР-2555/14.03.2013 |
29.03.2013 |
29.03.2013 |
Неактивен |
1729 |
| Ondansetron |
20011017 |
Zofran, Film coated tablet, 4, mg, Pack: 10 |
ГлаксоСмитКлайн ЕООД, България |
GlaxoSmith Kline Pharmaceuticals S.A. Poland; Glaxo Wellcome S.A., Spain |
40.37 |
8.07 |
48.44 |
4% |
1.61 |
41.98 |
8.4 |
50.38 |
16% |
6.46 |
48.44 |
9.69 |
58.13 |
|
КЦРР-2608/15.03.2013 |
29.03.2013 |
29.03.2013 |
Неактивен |
2488 |
| Ondansetron |
II-14470 / 16.10.2006 г. |
Zofran, Film coated tablet, 8, mg, Pack: 10 |
ГлаксоСмитКлайн ЕООД, България |
GlaxoSmithKline Pharmaceuticals SA, 189 Grunwaldzka Street, 60-322 Poznan, Poland; Glaxo Wellcome S.A., Avda. Extremadura 3, 09400 Aranda de Duero(Burgos), Spain |
93.88 |
18.78 |
112.66 |
4% |
3.76 |
97.64 |
19.53 |
117.17 |
16% |
15.02 |
112.66 |
22.53 |
135.19 |
|
КЦ-262/27.10.2008 |
18.11.2008 |
18.11.2008 |
Неактивен |
1729 |
| Ondansetron |
II-14469 / 16.10.2006 г. |
Zofran, Film coated tablet, 4, mg, Pack: 10 |
ГлаксоСмитКлайн ЕООД, България |
GlaxoSmithKline Pharmaceuticals SA, 189 Grunwaldzka Street, 60-322 Poznan, Poland; Glaxo Wellcome S.A., Avda. Extremadura 3, 09400 Aranda de Duero(Burgos), Spain |
51.22 |
10.24 |
61.46 |
4% |
2.05 |
53.27 |
10.65 |
63.92 |
16% |
8.2 |
61.47 |
12.29 |
73.76 |
|
КЦ-262/27.10.2008 |
18.11.2008 |
18.11.2008 |
Неактивен |
2488 |
| Ondansetron |
20011016 |
Zofran, Solution for injection, 2 mg/ml - 4 ml, -, Pack: 1 |
Novartis Pharma GmbH, Германия |
GlaxoSmithKline S.p.A., Italy |
9.04 |
1.81 |
10.85 |
7% |
0.63 |
9.67 |
1.93 |
11.6 |
20% |
1.81 |
11.48 |
2.3 |
13.78 |
промяна на обстоятелства НСР-9174/27.04.2016 |
НСР-6676/09.07.2015 |
25.07.2015 |
25.07.2015 |
Активен |
2772 |
| Ondansetron |
20011016 |
Zofran, Solution for injection, 2 mg/ ml- 4 ml, mg, Pack: 1 |
ГлаксоСмитКлайн ЕООД, България |
GlaxoSmithKline S.p.A., Italy |
9.04 |
1.81 |
10.85 |
7% |
0.63 |
9.67 |
1.93 |
11.6 |
20% |
1.81 |
11.48 |
2.3 |
13.78 |
|
НСР-6676/09.07.2015 |
25.07.2015 |
25.07.2015 |
Неактивен |
2772 |
| Ondansetron |
20011016 |
Zofran, Solution for injection, 2 mg/ ml- 4 ml, mg, Pack: 1 |
ГлаксоСмитКлайн ЕООД, България |
GlaxoSmithKline S.p.A., Italy |
9.41 |
1.88 |
11.29 |
7% |
0.66 |
10.07 |
2.01 |
12.08 |
20% |
1.88 |
11.95 |
2.39 |
14.34 |
|
НСР-3439/30.04.2014 |
22.05.2014 |
22.05.2014 |
Неактивен |
2772 |
| Ondansetron |
II-14981 / 24.11.2006 г. |
Zofran, Solution for injection, 2 mg/ ml- 4 ml, mg, Pack: 1 |
ГлаксоСмитКлайн ЕООД, България |
GlaxoSmithKline S.p.A., Italy |
10.44 |
2.09 |
12.53 |
6% |
0.63 |
11.07 |
2.21 |
13.28 |
18% |
1.88 |
12.95 |
2.59 |
15.54 |
|
КЦРР-2556/14.03.2013 |
29.03.2013 |
29.03.2013 |
Неактивен |
2772 |
| Ondansetron |
II-14981 / 24.11.2006 г. |
Zofran, Solution for injection, 2 mg/ ml- 4 ml, mg, Pack: 1 |
ГлаксоСмитКлайн ЕООД, България |
GlaxoSmithKline S.p.A., Strada Statale Asolana, 68 San Polo de Torrile 43056, Parma, Italy |
21.75 |
4.35 |
26.1 |
6% |
1.31 |
23.06 |
4.61 |
27.67 |
18% |
3.92 |
26.98 |
5.4 |
32.38 |
|
КЦ-262/27.10.2008 |
18.11.2008 |
18.11.2008 |
Неактивен |
2772 |
| Ondansetron |
II-14981 / 24.11.2006 г. |
Zofran, Solution for injection, 2 mg/ ml- 2 ml, mg, Pack: 1 |
ГлаксоСмитКлайн ЕООД, България |
GlaxoSmithKline S.p.A., Strada Statale Asolana, 68 San Polo de Torrile 43056, Parma, Italy |
10.99 |
2.2 |
13.19 |
6% |
0.66 |
11.65 |
2.33 |
13.98 |
18% |
1.98 |
13.63 |
2.73 |
16.36 |
цената се заличава КЦРР-933/04.07.2012 |
КЦ-262/27.10.2008 |
18.11.2008 |
18.11.2008 |
Заличен |
136 |
| Goserelin |
20020071 |
Zoladex, Implant, 3.6, mg, Pack: 1 |
Astra Zeneca AB, Швеция |
AstraZeneca UK Ltd, UK |
99.88 |
19.98 |
119.86 |
4% |
4 |
103.88 |
20.78 |
124.66 |
16% |
15.98 |
119.86 |
23.97 |
143.83 |
промяна на обстоятелства НСР-12038/20.03.2017; НСР-17611/20.12.2018 |
НСР-7911/28.01.2016.; НСР-12382/18.04.2017 |
03.05.2017 |
02.02.2019 |
Активен |
3240 |
| Goserelin |
20020071 |
Zoladex, Implant, 3.6, mg, Pack: 1 |
AstraZeneca UK Ltd, Обединено Кралство |
AstraZeneca UK Ltd, UK |
99.88 |
19.98 |
119.86 |
4% |
4 |
103.88 |
20.78 |
124.66 |
16% |
15.98 |
119.86 |
23.97 |
143.83 |
промяна на обстоятелства НСР-12038/20.03.2017 |
НСР-7911/28.01.2016.; НСР-12382/18.04.2017 |
03.05.2017 |
02.06.2017 |
Неактивен |
3240 |